MOAP-1, UBR5 and cisplatin resistance in ovarian cancer
Transl Cancer Res
.
2017 Feb;6(Suppl 1):S18-S21.
doi: 10.21037/tcr.2017.02.01.
Authors
Scott T Eblen
1
,
Amber Bradley
1
Affiliation
1
Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
PMID:
29607295
PMCID:
PMC5878060
DOI:
10.21037/tcr.2017.02.01
No abstract available
Publication types
Comment
Grants and funding
UL1 TR000062/TR/NCATS NIH HHS/United States